tiprankstipranks
Pharming Group (PHAR)
NASDAQ:PHAR
Holding PHAR?
Track your performance easily

Pharming Group (PHAR) Technical Analysis

111 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
2Neutral
5Bearish
Technical Analysis Consensus
Neutral
4Bullish
2Neutral
4Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Pharming Group’s (PHAR) Moving Averages Convergence Divergence (MACD) indicator is 0.21, suggesting Pharming Group is a Sell.
Pharming Group’s (PHAR) 20-Day exponential moving average is 8.23, while Pharming Group’s (PHAR) share price is $8.89, making it a Buy.
Pharming Group’s (PHAR) 50-Day exponential moving average is 8.16, while Pharming Group’s (PHAR) share price is $8.89, making it a Buy.

Pharming Group (PHAR) Pivot Points

Dec 23, 2024, 10:35 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
8.78
8.91
9.12
9.25
9.46
9.59
9.80
Fibonacci
8.91
9.04
9.12
9.25
9.38
9.46
9.59
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pharming Group (PHAR) Moving Averages

Dec 23, 2024, 10:35 PM
Period
Simple
Exponential
MA5
8.91Buy
8.85Buy
MA10
8.26Buy
8.49Buy
MA20
7.95Buy
8.23Buy
MA50
8.29Buy
8.16Buy
MA100
8.03Buy
8.31Buy
MA200
8.83Buy
9.15Sell
Pharming Group’s (PHAR) 10-Day exponential moving average is 8.49, while Pharming Group’s (PHAR) share price is $8.89, making it a Buy.
Pharming Group’s (PHAR) 100-Day exponential moving average is 8.31, while Pharming Group’s (PHAR) share price is $8.89, making it a Buy.
Pharming Group’s (PHAR) stock price is $8.89 and Pharming Group’s (PHAR) 50-day simple moving average is 8.29, creating a Buy signal.
Pharming Group’s (PHAR) stock price is $8.89 and Pharming Group’s (PHAR) 100-day simple moving average is 8.03, creating a Buy signal.
Pharming Group’s (PHAR) stock price is $8.89 and Pharming Group’s (PHAR) 200-day simple moving average is 8.83, creating a Buy signal.

Pharming Group (PHAR) Technical Indicators

Dec 23, 2024, 10:35 PM
Name
Value
Implied Action
RSI (14)
62.21
Neutral
STOCH (9,6)
81.61
Sell
STOCHRSI (14)
82.23
Sell
MACD (12,26)
0.21
Sell
ADX (14)
16.67
Buy
Williams %R
-27.23
Buy
CCI (14)
145.22
Sell
ATR (14)
0.47
-
Ultimate Oscillator
51.76
Neutral
ROC
19.26
Buy
Pharming Group’s (PHAR) Relative Strength Index (RSI) is 62.21, creating a Neutral signal.
Pharming Group’s (PHAR) Trend Strength Indicator (ADX) is 16.67, creating a Buy signal.
Pharming Group’s (PHAR) Commodity Channel Index (CCI) is 145.22, creating a Sell signal.
Pharming Group’s (PHAR) Price Rate of Change (ROC) is 19.26, creating a Buy signal.

FAQ

Is PHAR a Buy, Hold, or Sell?
Based on PHAR’s technical indicators, PHAR is a Buy.
    What is PHAR’s RSI (14)?
    PHAR’s RSI (14) is 62.21, which suggests PHAR is a Neutral.
      What is PHAR’s MACD?
      PHAR’s MACD is 0.21, which suggests PHAR is a Sell.
        What is PHAR’s 5-day moving average?
        PHAR’s 5-day moving average is 8.91, which suggests PHAR is a Buy.
          What is PHAR’s 20-day moving average?
          PHAR 20-day moving average is 7.95, which suggests PHAR is a Buy.
            What is PHAR’s 50-day moving average?
            PHAR’s 50-day moving average is 8.29, which suggests PHAR is a Buy.
              What is PHAR’s 200-day moving average?
              PHAR’s 200-day moving average is 8.83, which suggests PHAR is a Buy.
                What is PHAR’s Williams % R (14)?
                PHAR’s Williams % R (14) is -27.23, which suggests PHAR is a Buy.
                  What is PHAR’s CCI (14)?
                  PHAR’s CCI (14) is 145.22, which suggests PHAR is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis